Drug intelligence / Profile preview

Immunoglobulin G, A, and M

Development stage
Preclinical
Modality
Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

IgGAM is a preparation containing human immunoglobulins G, A, and M. It is used as an adjuvant therapy in severe infections such as sepsis and peritonitis. The drug exerts broad immunoregulatory effects by both enhancing immune responses (hyperinflammation) and suppressing excessive inflammation (hypoinflammation). Its mechanism of action includes pathogen elimination, endotoxin neutralization, modulation of the complement system to prevent tissue damage, and regulation of cytokine production. Clinical studies have shown that administration of IgGAM can improve survival in patients with severe infections like peritonitis[7]. Immunoglobulins are natural human proteins with established clinical use since the 1980s.

Other names
IgGAM
02

Targets

FCMR (Fc mu receptor)C1Q (Complement C1q)FCAR (Fc alpha receptor I)FcγR (Low affinity immunoglobulin gamma Fc region receptor II-c)

Beyond the preview

Go deeper on Immunoglobulin G, A, and M.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin G, A, and M.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call